The Current Ratio as of November 2024 (TTM) for DURECT Corporation (DRRX) is 0.91

According to DURECT Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.91. This represents a change of -18.02% compared to the average of 1.11 of the last 4 quarters.

DURECT Corporation (DRRX) Historical Current Ratio (quarterly & annually)

How has DRRX Current Ratio performed in the past?

The mean historical Current Ratio of DURECT Corporation over the last ten years is 4.04. The current 0.91 Current Ratio has changed 2.15% with respect to the historical average. Over the past ten years (40 quarters), DRRX's Current Ratio was at its highest in in the June 2021 quarter at 11.60. The Current Ratio was at its lowest in in the June 2024 quarter at 0.91.

DURECT Corporation (DRRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of DURECT Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DURECT Corporation (DRRX) Average Current Ratio

How has DRRX Current Ratio performed in the past?

The current Current Ratio of DURECT Corporation (DRRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

DURECT Corporation (DRRX) Current Ratio vs. Peers

How is DRRX’s Current Ratio compared to its peers?

DURECT Corporation’s Current Ratio is less than Shuttle Pharmaceuticals Holdings, Inc. (1.79), greater than Mallinckrodt plc (0.57), less than Organogenesis Holdings Inc. (2.73), greater than Lucy Scientific Discovery Inc. (0.38), less than Alimera Sciences, Inc. (2.79), less than Alpha Teknova, Inc. (4.76), greater than Agile Therapeutics, Inc. (0.55), less than Sonoma Pharmaceuticals, Inc. (3.12), less than Eagle Pharmaceuticals, Inc. (1.70), less than Lifecore Biomedical, Inc. (1.83), greater than RedHill Biopharma Ltd. (0.84), less than Taro Pharmaceutical Industries Ltd. (3.61), less than Collegium Pharmaceutical, Inc. (1.11), less than Neurocrine Biosciences, Inc. (4.37), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Ironwood Pharmaceuticals, Inc. (3.92), less than Alkermes plc (3.45), less than Avadel Pharmaceuticals plc (2.82), less than Aquestive Therapeutics, Inc. (7.49), less than Evoke Pharma, Inc. (1.28), greater than Adamis Pharmaceuticals Corporation (0.58), less than Guardion Health Sciences, Inc. (16.67), less than AcelRx Pharmaceuticals, Inc. (4.04),

Build a custom stock screener for DURECT Corporation (DRRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DURECT Corporation (DRRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.